Oyster Point Pharma Stock Price, News & Analysis
Company Description
Oyster Point Pharma (NASDAQ: OYST) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector. The company has a market capitalization of $299.9M.
OYST stock has declined 41.1% over the past year.
This page provides a comprehensive overview of OYST stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Oyster Point Pharma (OYST) stock. Over the past 12 months, the stock has lost 41.1%. At a market capitalization of $299.9M, OYST is classified as a micro-cap stock with approximately 26.8M shares outstanding.
Latest News
Oyster Point Pharma has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, acquisition, conferences. View all OYST news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
OYST Company Profile & Sector Positioning
Oyster Point Pharma (OYST) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.